News from pds biotechnology corporation A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

13 Apr, 2016, 11:00 BST PDS Biotechnology Reports Positive Phase 1 Study Results for PDS0101 Immunotherapy for HPV-Related Cancers

PDS Biotechnology has completed a successful Phase 1 clinical study of its lead cancer immunotherapy, PDS0101, focused on the treatment of...


09 Feb, 2016, 11:00 GMT PDS Biotechnology Signs Agreement with National Cancer Institute to form Phase II clinical collaboration for novel cancer immunotherapies based on PDS' Versamune® platform technology

PDS Biotechnology (PDS), a clinical-stage biopharmaceutical company focused on developing a pipeline of simpler, safer and more effective cancer...


20 Jan, 2016, 11:00 GMT Immunotherapy Company PDS Biotechnology Strengthens Senior Management Team, Adds Two Drug Development Executives

PDS Biotechnology, a clinical-stage biotechnology company developing cancer immunotherapies, is pleased to announce the appointments of Dr. Robert...


18 Dec, 2014, 15:40 GMT PDS Biotechnology, Inc. Announces Appointment of Biotech Industry Leader Sir Richard Sykes to its Board of Directors as Executive Chairman

PDS Biotechnology, a clinical stage immunotherapeutics company developing the powerful Versamune® nanoparticle technology, is delighted to announce...


17 Apr, 2013, 00:00 BST Novel Cancer Immunotherapy set to enter Clinical Trials

PDS Biotechnology Corporation today presented a summary of the company's preclinical data on its lead cancer immunotherapy PDS0101 at the World...


09 Jul, 2012, 06:00 BST PDS Biotechnology Corporation Signs Worldwide Licensing Agreement with Merck KGaA for Versamune™

PDS Biotechnology Corporation announced today that they have entered into an exclusive worldwide licensing agreement with Merck KGaA, Darmstadt,...